ADAM SCOTT NORBERG

Allopathic & Osteopathic Physicians|Dermatology PHOENIX, AZ NPI 1487048583

General Payments — all program years on this page

$626.16

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $458.75 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $458.7522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $24.001
2020 $92.251
2023 $51.162
2024 $458.7522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078278105 Janssen Biotech, Inc. $23.57 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078281077 Janssen Biotech, Inc. $24.34 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101589395 E.R. Squibb & Sons, L.L.C. $16.24 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101589399 E.R. Squibb & Sons, L.L.C. $15.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105132511 ABBVIE INC. $26.81 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105132513 ABBVIE INC. $15.30 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117340803 Amgen Inc. $17.05 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121032478 Arcutis Biotherapeutics, Inc. $23.11 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127913005 Dermavant Sciences, Inc. $18.52 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127913009 Dermavant Sciences, Inc. $19.71 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127913012 Dermavant Sciences, Inc. $14.91 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127913016 Dermavant Sciences, Inc. $25.80 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136009053 Lilly USA, LLC $14.14 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139910581 GENZYME CORPORATION $23.46 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141285935 Incyte Corporation $19.82 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143352146 UCB, Inc. $20.29 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143352150 UCB, Inc. $26.47 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152120396 SUN PHARMACEUTICAL INDUSTRIES INC. $19.05 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152120398 SUN PHARMACEUTICAL INDUSTRIES INC. $25.57 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152120400 SUN PHARMACEUTICAL INDUSTRIES INC. $20.22 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152120402 SUN PHARMACEUTICAL INDUSTRIES INC. $24.71 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152644723 LEO Pharma Inc. $23.93 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.